relapsed acute lymphoblastic leukemia
Showing 1 - 7 of 7
Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)
Active, not recruiting
- Lymphoid Leukemia
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,
Completed
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Pevonedistat
- +7 more
-
Miami, FloridaUniversity of Miami
Oct 19, 2022
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- +2 more
- Palbociclib
- +3 more
-
Stanford, CaliforniaLucile Packard Children's Hospital Stanford
Sep 20, 2021
Relapsed Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Shenzhen (CD19 CART)
Unknown status
- Relapsed Acute Lymphoblastic Leukemia
- Refractory Acute Lymphoblastic Leukemia
- CD19 CART
-
Shenzhen, ChinaShenzhen University General Hospital
Jul 7, 2019
Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase Trial in Los
Terminated
- Relapsed Acute Lymphoblastic Leukemia
- +2 more
- Erwinase
- +7 more
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Oct 2, 2018
Relapsed Acute Lymphoblastic Leukemia, Relapsed Acute Myelogenous Leukemia Trial in United States (GNKG168)
Terminated
- Relapsed Acute Lymphoblastic Leukemia
- Relapsed Acute Myelogenous Leukemia
-
Phoenix, Arizona
- +28 more
Nov 22, 2015